|
PF-41406 |
CERVARIX Suspensión inyectable |
2023-09-19 |
|
GlaxoSmithkline Biologicals, S.A. |
Bélgica
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-42911 |
TRITANRIX HB suspension inyectable |
2014-05-07 |
|
GlaxoSmithkline Biologicals, S.A. |
Bélgica
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-43912 |
SYNFLORIX Suspensión inyectable |
2024-11-25 |
|
GlaxoSmithkline Biologicals, S.A. |
Bélgica
|
J.I.Cohen, S.A. |
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-44787 |
VAMMRIX Polvo y disolvente para solución inyectable |
2024-08-08 |
|
GlaxoSmithkline Biologicals, S.A. |
Bélgica
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-47045 |
BOOSTRIX Suspensión Inyectable |
2026-08-20 |
|
GlaxoSmithkline Biologicals, S.A. |
Bélgica
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-39810 |
CUTIVATE 0.05 % Crema tópica |
2026-09-23 |
|
Glaxosmithkline Brasil Ltda. |
Brasil
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-39845 |
ZOVIRAX 5% Crema Tópica |
2028-01-06 |
|
Glaxosmithkline Brasil Ltda. |
Brasil
|
J.I.Cohen, S.A. |
Glaxosmithkline Guatemala |
Centro Distribuidor, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-39886 |
BETNOVATE 0.1 % Crema tópica |
2027-01-28 |
|
Glaxosmithkline Brasil Ltda. |
Brasil
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-41239 |
DERMOVATE 0.05 % Ungüento tópico |
2027-11-18 |
|
Glaxosmithkline Brasil Ltda. |
Brasil
|
J.I.Cohen, S.A. |
Glaxosmithkline Guatemala |
Centro Distribuidor, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-38033 |
TUMS REGULAR 500 mg Tabletas Masticables sabores varios |
2016-09-20 |
|
Glaxosmithkline Consumer Healthcare |
Estados Unidos de América
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|